EMA — authorised 27 March 2020
- Marketing authorisation holder: Bayer AG
- Status: approved
🇪🇺 Nubeqa in European Union
EMA authorised Nubeqa on 27 March 2020
Marketing authorisation
Nubeqa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Nubeqa approved in European Union?
Yes. EMA authorised it on 27 March 2020.
Who is the marketing authorisation holder for Nubeqa in European Union?
Bayer AG holds the EU marketing authorisation.